evidencegaps
Primary study · included by 1 review

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.

Sathekge 2024 · Sathekge Mike M, Lawal Ismaheel O, Bal Chandrasekhar, et al. · The Lancet. Oncology · 2024

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.
Non-Cochrane · intervention · 2026 · cited as Sathekge 2024 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.